Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas

Gerth, HU; Pohlen, M; Tholking, G; Pavenstadt, H; Brand, M; Husing-Kabar, A; Wilms, C; Maschmeier, M; Kabar, I; Torner, J; Pavesi, M; Arroyo, V; Banares, R; Schmidt, HHJ.

Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective Analysis

CRITICAL CARE MEDICINE. 2017; 45(10): 1616-1624 Nº de citas: 47 [doi:10.1097/CCM.0000000000002562]

Reguera-Berenguer, L; Orcajo-Rincon, J; Rotger-Regi, A; Matilla-Pena, AM; Echenagusia-Boyra, M; Perez-Pascual, R; Mari-Hualde, A; Alonso-Farto, JC.

Downstaging of bilobar hepatocellular carcinoma after radioembolization with Y-90 microspheres as a bridge to liver transplantation

Revista Espanola de Medicina Nuclear e Imagen Molecular. 2017; 36(5): 329-332 Nº de citas: 2 [doi:10.1016/j.remn.2016.12.006]

Marin-Jimenez, I; Montoya, MG; Panadero, A; Canas, M; Modino, Y; de Santos, CR; Guardiola, J; Carmona, L; Barreiro-de Acosta, M; ACCU.

Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project

INFLAMMATORY BOWEL DISEASES. 2017; 23(9): 1492-1498 Nº de citas: 20 [doi:10.1097/MIB.0000000000001205]

de la Cruz, MH; Acuna, JAM; Ros, AL; Catalina, MV; Paniagua, ES; Ricote, GC; Frutos, CDD; Gines, MLM.

Hepatotoxicity after high-dose intravenous methylprednisolone in multiple sclerosis patients

Clinical Case Reports. 2017; 5(8): 1210-1212 Nº de citas: 5 [doi:10.1002/ccr3.1033]

Taxonera, C; Rodriguez, C; Bertoletti, F; Menchen, L; Arribas, J; Sierra, M; Arias, L; Martinez-Montiel, P; Juan, A; Iglesias, E; Algaba, A; Mancenido, N; Rivero, M; Barreiro-de Acosta, M; Lopez-Serrano, P; Arguelles-Arias, F; Gutierrez, A; Busquets, D; Gisbert, JP; Olivares, D; Calvo, M; Alba, C; Collaborators.

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

INFLAMMATORY BOWEL DISEASES. 2017; 23(8): 394-402 Nº de citas: 70 [doi:10.1097/MIB.0000000000001144]

Diaz-Fontenla, F; Castillo-Pradillo, M; Diaz-Gomez, A; Ibanez-Samaniego, L; Gancedo, P; Guzman-de-Villoria, JA; Fernandez-Garcia, P; Banares-Canizares, R; Garcia-Martinez, R.

y Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism

WORLD JOURNAL OF GASTROENTEROLOGY. 2017; 23(28): 5246-5252 Nº de citas: 13 [doi:10.3748/wjg.v23.i28.5246]

de Lope, CR; Reig, M; Matilla, A; Ferrer, MT; Duenas, E; Minguez, B; Castroagudin, JF; Ortiz, I; Pascual, S; Lledo, JL; Gallego, A; Arenas, JI; Aracil, C; Forne, M; Munoz, C; Pons, F; Sala, M; Inarrairaegui, M; Martin-Llahi, M; Andreu, V; Garre, C; Rendon, P; Fuentes, J; Crespo, J; Rodriguez, M; Bruix, J; Varela, M.

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers

MEDICINA CLINICA. 2017; 149(2): 61-71 Nº de citas: 15 [doi:10.1016/j.medcli.2016.12.048]

Nogales, O; Clemente, A; Caballero-Marcos, A; Garcia-Lledo, J; Perez-Carazo, L; Merino, B; Lopez-Ibanez, M; Perez-Valderas, MD; Banares, R; Gonzalez-Asanza, C.

Endoscopically placed stents: a useful alternative for the management of refractory benign cervical esophageal stenosis

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2017; 109(7): 510-515 Nº de citas: 10 [doi:10.17235/reed.2017.4795/2016]

Taxonera, C; Ponferrada, A; Bermejo, F; Riestra, S; Saro, C; Martin-Arranz, MD; Cabriada, JL; Barreiro-de Acosta, M; de Castro, ML; Lopez-Serrano, P; Barrio, J; Suarez, C; Iglesias, E; Arguelles-Arias, F; Ferrer, I; Marin-Jimenez, I; Hernandez-Camba, A; Bastida, G; Van Domselaar, M; Martinez-Montiel, P; Olivares, D; Alba, C; Gisbert, JP.

Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

JOURNAL OF CROHNS & COLITIS. 2017; 11(7): 792-800 Nº de citas: 14 [doi:10.1093/ecco-jcc/jjx022]

Munoz-Gomez, R; Rincon, D; Ahumada, A; Hernandez, E; Devesa, MJ; Izquierdo, S; Ortiz, M; Hernandez-Albujar, A; Fernandez-Rodriguez, C; Calvo, M; Gonzalez, R; Lozano, M; Castellano, G; Fernandez-Vazquez, I.

Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience

JOURNAL OF VIRAL HEPATITIS. 2017; 24(6): 464-471 Nº de citas: 39 [doi:10.1111/jvh.12664]

Calleja, JL; Crespo, J; Rincon, D; Ruiz-Antoran, B; Fernandez, I; Perello, C; Gea, F; Lens, S; Garcia-Samaniego, J; Sacristan, B; Garcia-Eliz, M; Llerena, S; Pascasio, JM; Turnes, J; Torras, X; Morillas, RM; Llaneras, J; Serra, MA; Diago, M; Rodriguez, CF; Ampuero, J; Jorquera, F; Simon, MA; Arenas, J; Navascues, CA; Banares, R; Munoz, R; Albillos, A; Marino, Z.

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

JOURNAL OF HEPATOLOGY. 2017; 66(6): 1138-1148 Nº de citas: 157 [doi:10.1016/j.jhep.2017.01.028]

Yotti, R; Ripoll, C; Benito, Y; Catalina, MV; Elizaga, J; Rincon, D; Fernandez-Aviles, F; Bermejo, J; Banares, R.

Left Ventricular Systolic Function Is Associated With Sympathetic Nervous Activity and Markers of Inflammation in Cirrhosis

HEPATOLOGY. 2017; 65(6): 2019-2030 Nº de citas: 50 [doi:10.1002/hep.29104]

Carrillo, CF; Lens, S; Llop, E; Pascasio, JM; Crespo, J; Arenas, J; Fernandez, I; Baliellas, C; Carrion, JA; de la Mata, M; Buti, M; Castells, L; Albillos, A; Romero, M; Turnes, J; Pons, C; Moreno-Planas, JM; Moreno-Palomares, JJ; Fernandez-Rodriguez, C; Garcia-Samaniego, J; Prieto, M; Bermejo, MF; Salmeron, J; Badia, E; Salcedo, M; Herrero, JI; Granados, R; Ble, M; Marino, Z; Calleja, JL.

Treatment of Hepatitis C Virus Infection in Patients With Cirrhosis and Predictive Value of Model for End-Stage Liver Disease: Analysis of Data From the Hepa-C Registry

HEPATOLOGY. 2017; 65(6): 1810-1822 Nº de citas: 77 [doi:10.1002/hep.29097]

Crespo, J; Calleja, JL; Fernandez, I; Sacristan, B; Ruiz-Antoran, B; Ampuero, J; Hernandez-Conde, M; Garcia-Samaniego, J; Gea, F; Buti, M; Cabezas, J; Lens, S; Morillas, RM; Salcines, JR; Pascasio, JM; Turnes, J; Saez-Royuela, F; Arenas, J; Rincon, D; Prieto, M; Jorquera, F; Ruano, JJS; Navascues, CA; Molina, E; Moya, AG; Moreno-Planas, JM.

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2017; 15(6): 945-949 Nº de citas: 24 [doi:10.1016/j.cgh.2017.02.020]

Asencio, JM; Garcia-Sabrido, JL; Lopez-Baena, JA; Ohnedilla, L; Peligros, I; Lozano, P; Morales-Taboada, A; Fernandez-Mena, C; Steiner, MA; Sola, E; Perez-Pena, JM; Herrero, M; Laso, J; Lisbona, C; Banares, R; Casanova, J; Vaquero, J.

Preconditioning by portal vein embolization modulates hepatic hemodynamics and improves liver function in pigs with extended hepatectomy

SURGERY. 2017; 161(6): 1489-1501 Nº de citas: 15 [doi:10.1016/j.surg.2016.12.003]

Aguiar, D; Martinez-Urbistondo, D; Baroja-Mazo, A; de la Mata, M; Rodriguez-Peralvarez, M; Rubin, A; Puchades, L; Serrano, T; Montero, J; Cuadrado, A; Casafont, F; Salcedo, M; Rincon, D; Pons, JA; Herrero, JI.

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients

ANNALS OF TRANSPLANTATION. 2017; 22: 265-275 Nº de citas: 9 [doi:10.12659/AOT.902523]

Aguero, F; Forner, A; Valdivieso, A; Blanes, M; Barcena, R; Manzardo, C; Rafecas, A; Castells, L; Abradelo, M; Barrera-Baena, P; Gonzalez-Dieguez, L; Salcedo, M; Serrano, T; Jimenez-Perez, M; Herrero, JI; Gastaca, M; Aguilera, V; Fabregat, J; del Campo, S; Bilbao, I; Romero, CJ; Moreno, A; Rimola, A; Miro, JM; FIPSE Investigators.

Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study

LIVER TRANSPLANTATION. 2017; 23(5): 645-651 Nº de citas: 4 [doi:10.1002/lt.24741]

Alonso, S; Riveiro-Barciela, M; Fernandez, I; Rincon, D; Real, Y; Llerena, S; Gea, F; Olveira, A; Fernandez-Carrillo, C; Polo, B; Carrion, JA; Gomez, A; Devesa, MJ; Baliellas, C; Castro, A; Ampuero, J; Granados, R; Pascasio, JM; Rubin, A; Salmeron, J; Badia, E; Planas, JMM; Lens, S; Turnes, J; Montero, JL; Buti, M; Esteban, R; Fernandez-Rodriguez, CM.

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

JOURNAL OF VIRAL HEPATITIS. 2017; 24(4): 304-311 Nº de citas: 34 [doi:10.1111/jvh.12648]